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The frequency, cost and harms of the procedure must have
been weighed up by the British National Health Service (NHS)
— usually pretty sensible about their medical
recommendations — which proposed 3-yearly screening for
women aged between 50 and 64 years. Obviously more cancers
would be discovered by 2-yearly rather than 3-yearly
screening, and yet more by annual screening. Six-monthly
screening, in turn, would clearly yield more cancers than
annual screening.  This would fit well with Dr Whitehorn’s
‘simple arithmetic’. However a balance has to be found
between benefits and harms, and we chose the NHS one. The
following organised screening programmes recommend 2-
yearly mammography, most of them for women between 50
and 69 years: Australia, Finland, Iceland, Israel, Netherlands,
France, Belgium, Canada, Denmark, Ireland, Italy, Norway,
Portugal and Greece. Annual mammography, and
mammography at an early age are the usual recommendations
of interest groups. They are also the recommendation of the
correspondence printed above.
Like Dr Paul Sneider, we conclude with a quote from Boyle:
‘Every woman has a right to participate in an organised
screening program . . .’. This right, alas, does not apply to this
country, where other health care priorities make an organised
programme an impossibility. However, should a woman have
the privilege of medical aid, or be able to afford  mammo-
graphy, it is her choice to undergo it, a choice open to only a
minority of South Africans. The majority of South African
women would, in our opinion, be well served by an organised
programme of ‘breast awareness’, a proposal that Dr Russell
Whitehorn finds difficult to fathom.
Failed contraception?
To the Editor: We read with interest the article by Van Bogaert
regarding contraceptive use among women seeking
termination of pregnancy (TOP).1 Given the high burden of
unwanted pregnancy in South Africa this research is of great
importance. However we take issue with the specific
methodological approach and subsequent inferences that may
be drawn regarding contraceptive effectiveness.
Specifically, the use of non-pregnant women attending
gynaecological outpatient services as a control group, without
statistical adjustment for underlying differences that may
confound this comparison, is problematic. Despite the author’s
assertion that the ‘demography was comparable’ in the two
groups, the data presented in Tables I and II show that the
controls are substantially older and have greater parity
compared with women seeking TOP. For example, almost 40%
of controls were over 30 years of age, compared with
approximately 20% of women seeking TOP. While statistical
methods could be used to adjust for these differences, no such
methods were employed in the study, and only unadjusted
associations are reported.
There is evidence that methods of contraception differ with
age in South Africa, with oral contraception (OC) more
common among younger women than older women.2-4 In this
light, the differences described in the paper in contraceptive
methods may be attributed to the demographic differences
between the two groups, rather than differential contraceptive
failure rates. This explanation is also more in keeping with
evidence regarding contraceptive failure rates, which suggest
that with ‘perfect use’, injectable and oral contraceptives have
comparable failure rates; under ‘real life’ conditions, OC may
fail only slightly more frequently than injectables due to user
error.5 Furthermore, reporting of contraceptive method use may
be different among women seeking TOP and controls. Lack of
information on how contraceptive information was collected
makes it difficult to rule out this possibility.
Without an understanding of the methodological limitations
of this study, readers may draw inferences from these data
about a relationship between OC use and failed contraception.
From a public health perspective, it is extremely important to
avoid statements that could be incorrectly interpreted as
suggesting that OC is less effective than injectable
contraception. More generally, additional research examining
the relationship between contraception, method choice, and the
occurrence of unwanted pregnancy in South Africa is clearly
needed. We thank Van Bogaert for focusing attention on this
important women’s health issue.
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Medical practitioners’ attitudes
towards older patients
To the Editor: Population ageing will see South Africa’s
population aged 60 years and over increase from 6% to 14% of
the total population by 2050. It is projected that  the 80-plus age
group will more than double, from 8% to 19% of the older
population.1 Longevity and an expanded very-old age group
will result in an increased prevalence of age-associated chronic
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